Copyright
©The Author(s) 2022.
World J Gastrointest Endosc. Apr 16, 2022; 14(4): 215-225
Published online Apr 16, 2022. doi: 10.4253/wjge.v14.i4.215
Published online Apr 16, 2022. doi: 10.4253/wjge.v14.i4.215
All patients | P value | Propensity score-matched patients | P value | |||
Patients with a PS 0-2 | Patients with a PS 3 or 4 | Patients with a PS 0-2 | Patients with a PS 3 or 4 | |||
Overall complications, n (%) | 100 (9.0) | 16 (7.0) | 0.37 | 9 (4.6) | 13 (6.6) | 0.51 |
Severity of overall complications | 0.063 | 0.042 | ||||
Mild (%) | 65 (65.0) | 6 (37.5) | 7 (77.8) | 3 (23.1) | ||
Moderate (%) | 29 (29.0) | 8 (50.0) | 2 (22.2) | 8 (61.5) | ||
Severe (%) | 6 (6.0) | 2 (12.5) | 0 (0.0) | 2 (15.4) | ||
PEP (%) | 50 (4.5) | 5 (2.2) | 0.14 | 3 (1.5) | 2 (1.0) | 1.0 |
Severity of PEP (%) | 0.034 | 0.10 | ||||
Mild (%) | 34 (68.0) | 3 (60.0) | 3 (100.0) | 0 (0.0) | ||
Moderate (%) | 14 (28.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
Severe (%) | 2 (4.0) | 2 (40.0) | 0 (0.0) | 2 (100.0) | ||
Bleeding (%) | 18 (1.6) | 4 (1.7) | 0.78 | 1 (0.5) | 4 (2.0) | 0.37 |
Severity of bleeding (%) | 0.12 | 0.40 | ||||
Mild (%) | 12 (66.7) | 1 (25.0) | 1 (100.0) | 1 (25.0) | ||
Moderate (%) | 3 (16.7) | 3 (75.0) | 0 (0.0) | 3 (75.0) | ||
Severe (%) | 3 (16.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
Cholangitis (%) | 18 (1.6) | 4 (1.7) | 0.78 | 3 (1.5) | 4 (2.0) | 1.0 |
Severity of cholangitis (%) | 0.077 | 0.49 | ||||
Mild (%) | 14 (77.8) | 1 (25.0) | 2 (66.7) | 1 (25.0) | ||
Moderate (%) | 4 (22.2) | 3 (75.0) | 1 (33.3) | 3 (75.0) | ||
Perforation (%) | 10 (0.9) | 0 (0.0) | 0.23 | 1 (0.5) | 0 (0.0) | 1.0 |
Severity of perforation (%) | 1.0 | NA | ||||
Mild (%) | 4 (40.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
Moderate (%) | 5 (50.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) | ||
Severe (%) | 1 (10.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
Pneumonia (%) | 4 (0.4) | 3 (1.3) | 0.10 | 1 (0.5) | 3 (1.5) | 0.62 |
Severity of aspiration pneumonia (%) | 1.0 | 1.0 | ||||
Mild (%) | 1 (25.0) | 1 (33.3) | 1 (100.0) | 1 (33.3) | ||
Moderate (%) | 3 (75.0) | 2 (66.7) | 0 (0.0) | 2 (66.7) |
- Citation: Saito H, Kadono Y, Shono T, Kamikawa K, Urata A, Nasu J, Imamura H, Matsushita I, Kakuma T, Tada S. Endoscopic retrograde cholangiopancreatography for bile duct stones in patients with a performance status score of 3 or 4. World J Gastrointest Endosc 2022; 14(4): 215-225
- URL: https://www.wjgnet.com/1948-5190/full/v14/i4/215.htm
- DOI: https://dx.doi.org/10.4253/wjge.v14.i4.215